NCBP1

Across TCGA pan-cancer cohorts, NCBP1 mass-spec protein differs between tumor and matched normal tissue in 7 of 18 cancer types tested, making tumor–normal expression one of NCBP1’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where NCBP1 mass-spec protein is more highly expressed in tumor relative to normal tissue. In most cancer types NCBP1 is over-expressed in tumor, although a few such as PDAC and CCRCC show the opposite, repressed pattern.

HNSC, COAD, and LUAD are the cancer types where NCBP1 tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in NCBP1 mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	Male	IV	+0.700	<.001	12	view →
COAD	Male	III,IV	+0.567	<.001	11	view →
LUAD	Male	All	+0.370	<.001	9	view →
LSCC	Male	II,III,IV	+0.566	<.001	8	view →
PDAC	Female	II,III,IV	−0.220	<.001	4	view →
OV	All	All	+0.402	.007	2	view →
CCRCC	Male	II,III,IV	−0.071	.030	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 7 strongest of 7 lineages.

NCBP1–HNSC

Open the HNSC breakdown →